“…Mitomycin-C, an antibiotic used as an antineoplastic and antifibrotic agent, has been previously used in topical applications to prevent scar formation and recurrence of stricture after ophthalmological surgery (4), in recurrent laryngeal and tracheal stenosis (5), and after dacryocystorhinostomy (6). A few small series (7)(8)(9) and case reports (10)(11)(12)(13)(14) have also suggested that mitomycin-C could have a prophylactic role in avoiding postoperative fibrosis when used in patients with esophageal strictures of various origins (peptic, caustic, postoperative). In these series, only a few cases of esophageal stricture following surgery for congenital EA have been reported.…”